I have probable bipolar II, am stable on lamotrigine 200 mg daily and bupropion, and experience occasional anxiety; is prescribing pregabalin (Lyrica) for insomnia and escitalopram (Cipralex) for anxiety appropriate, or should I consider other options?

Pregabalin (Lyrica) for Insomnia and Escitalopram (Cipralex) for Anxiety in Bipolar II: Not Recommended

Pregabalin is not an evidence-based treatment for insomnia and should not be used for this indication in your case. The American Academy of Sleep Medicine 2017 guidelines explicitly do not recommend anticonvulsants (including pregabalin's class) for chronic insomnia, and pregabalin is FDA-approved only for neuropathic pain, fibromyalgia, and seizures—not sleep disorders 1, 2.

Critical Concerns with the Proposed Regimen

Pregabalin for Sleep: Lacks Evidence and Carries Risks

• No guideline support: The AASM 2017 guidelines reviewed anticonvulsants and found insufficient evidence to recommend them for insomnia. Tiagabine (another anticonvulsant) received a negative recommendation 1.

• Minimal research support: A 2022 systematic review found "inconclusive" results for gabapentinoids in insomnia, with no robust evidence supporting their use 3.

• Significant safety concerns in bipolar disorder: The FDA label warns that pregabalin can cause or worsen depression, mood problems, and suicidal thoughts—particularly dangerous in bipolar disorder 2. It also causes dizziness, weight gain, and has abuse potential as a controlled substance.

• Not FDA-approved for insomnia: Pregabalin's approved indications do not include sleep disorders 2.

Escitalopram for Anxiety: High Risk in Bipolar II

Adding an SSRI like escitalopram to your regimen carries substantial risk of triggering hypomania or rapid cycling in bipolar II disorder, even with lamotrigine on board. The 2018 CANMAT/ISBD guidelines emphasize that antidepressant monotherapy or addition must be approached with extreme caution in bipolar disorder 4, 5.

• Switch risk: SSRIs can destabilize mood in bipolar disorder, potentially inducing hypomanic episodes or accelerating cycling.

• Limited evidence for anxiety in bipolar: No randomized controlled trials exist for treating comorbid bipolar disorder and anxiety disorders 6.

Evidence-Based Alternatives

For Insomnia in Bipolar II

First-line pharmacologic options per AASM 2017 guidelines 1:

• Eszopiclone (2-3 mg): Effective for both sleep onset and maintenance
• Zolpidem (10 mg): Effective for sleep onset and maintenance
• Suvorexant: Specifically for sleep maintenance insomnia
• Doxepin (3-6 mg): Low-dose formulation for sleep maintenance

Critical caveat: Cognitive-behavioral therapy for insomnia (CBT-I) should be the primary intervention before or alongside any medication 1.

For Anxiety in Bipolar II

Safer options that don't destabilize mood 4, 6:

1. Optimize lamotrigine: Ensure you're at an adequate dose for mood stabilization, which may help anxiety symptoms.

2. Consider quetiapine: Has evidence for both bipolar depression and anxiety symptoms, with first-line status in bipolar disorder 4, 5.

3. Pregabalin for anxiety (NOT sleep): If anxiety is the primary target, pregabalin actually has moderate evidence for generalized and social anxiety disorders 3, 6, 7. However, this must be weighed against the mood destabilization risks in bipolar disorder.

4. Avoid antidepressant monotherapy: If an SSRI is absolutely necessary for severe anxiety, it should only be added after mood is fully stabilized on an adequate mood stabilizer, with close monitoring for mood switching 4, 8.

Bupropion Consideration

Your current bupropion may be contributing to anxiety symptoms. A 2025 review found that bupropion's stimulating properties can provoke or worsen anxiety, particularly at higher doses 9. Consider whether dose reduction or discontinuation might help before adding new medications.

Recommended Approach

1. Address insomnia first with CBT-I and/or an AASM-recommended agent (eszopiclone, zolpidem, or low-dose doxepin) 1.

2. For anxiety, optimize your mood stabilizer (lamotrigine) first, consider quetiapine addition, or evaluate whether bupropion is exacerbating symptoms 9, 5.

3. Avoid pregabalin for sleep—it lacks evidence and carries mood destabilization risks in bipolar disorder 2, 3.

4. Avoid adding escitalopram unless anxiety is severe and refractory to other interventions, and only with very close monitoring for mood switching 4, 5.

The proposed regimen prioritizes off-label medications with weak or absent evidence while ignoring guideline-supported alternatives and the specific risks of your bipolar II diagnosis.